跳至主要内容
临床试验/NCT06952140
NCT06952140尚未招募不适用

Hemodynamic Effects of Ketone Esters in Patients With Sepsis Induced Cardiomyopathy

Tor Biering-Sørensen0 个研究点目标入组 12 人开始时间: 2026年3月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
12
主要终点
Global longitudinal strain

研究概览

简要总结

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and is associated with a high mortality rate in the ICU. Sepsis induced cardiomyopathy (SICM) is a multi-factorial process that appears in approximately 50% of patients with sepsis/septic shock and is associated with increased mortality. It is suggested that ketone bodies are more efficient substrates of energy metabolism than glucose, with a lower oxygen consumption per ATP-molecule produced and that the failing human heart increases the capacity to metabolize ketones. Previous studies have found acute beneficial hemodynamic effects of ketone esters in patients with chronic heart failure and cardiogenic shock, respectively. Improved hemodynamics and reduced systemic oxygen consumption as an effect of ketone esters might be of great benefit in patients admitted to the ICU. Thus, the investigators aim to investigate the hemodynamic effects of ketone esters in patients with sepsis induced cardiomyopathy in this randomized, placebo-controlled, double-blinded, cross-over, acute intervention study. .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients ≥ 18 years of age admitted to the the intensive care unit (ICU)
  • •LVEF < 50% determined by a screening echocardiography and analysed according to the Simpson biplane method
  • •Ability for study personnel to perform transthoracic echocardiography
  • •Suspected or documented infection (suspected infection is defined as ongoing antibiotic treatment and/or body fluid culture sampling performed within 72 hours before screening)

排除标准

  • •Diagnosis of heart failure with reduced ejection fraction prior to ICU admission according to health records
  • •Surgical cause of ICU admission
  • •For patients in shock: Other primary causes of shock than sepsis (i.e. hypovolemia, haemorrhage, cardiogenic etiology, pulmonary embolism, anaphylaxis)
  • •Blood pH < 7.20
  • •Severe gastroparesis
  • •Inability to position a nasogastric tube

研究组 & 干预措施

Placebo followed by ketone ester

Experimental

干预措施: Placebo (Dietary Supplement)

Ketone ester followed by placebo

Experimental

干预措施: Placebo (Dietary Supplement)

Placebo followed by ketone ester

Experimental

干预措施: Ketone ester (Dietary Supplement)

Ketone ester followed by placebo

Experimental

干预措施: Ketone ester (Dietary Supplement)

结局指标

主要结局

Global longitudinal strain

时间窗: From intervention to 3 hours after intervention (this is assessed for both treatment arms)

Echocardiographic measure obtained from transthoracic echocardiography

次要结局

  • Mean arterial pressure(From intervention to 3 hours after intervention (this is assessed for both treatment arms))
  • Left ventricular ejection fraction(From intervention to 3 hours after intervention (this is assessed for both treatment arms))
  • Cardiac output(From intervention to 3 hours after intervention (this is assessed for both treatment arms))
  • Arterial blood lactate(From intervention to 3 hours after intervention (this is assessed for both treatment arms))
  • Peripheral blood oxygen saturation(From intervention to 3 hours after intervention (this is assessed for both treatment arms))
  • Arterial blood pH(From intervention to 3 hours after intervention (this is assessed for both treatment arms))
  • Accumulated norepinephrine(From intervention to 3 hours after intervention (this is assessed for both treatment arms))

研究者

发起方
Tor Biering-Sørensen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Tor Biering-Sørensen

Professor, MD, MSc, MPH, PhD

Herlev and Gentofte Hospital

相似试验